Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes-Reference-Cited by-同舟云学术

Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes

Published:2018-10 Issue: Volume:124 Page:95-101
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Churg Andrew,Nabeshima Kazuki,Ali Greta,Bruno Rossella,Fernandez-Cuesta Lynnette,Galateau-Salle Francoise

Funder

Japanese Society for the Promotion of Science

National Cancer Institute INCA

National Institutes of Health/National Cancer Institute Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. New markers for separating benign from malignant mesothelial proliferations: are we there yet?;Churg;Arch. Pathol. Lab. Med.,2016

2. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry;Hida;Lung Cancer,2017

3. Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group;Husain;Arch. Pathol. Lab. Med.,2018

4. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations;Sheffield;Am. J. Surg. Pathol.,2015

5. Malignant pleural mesothelioma and mesothelial hyperplasia: a new molecular tool for the differential diagnosis;Bruno;Oncotarget,2017

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimally Invasive, Maximally Effective;Surgical Pathology Clinics;2024-09

2. Health Outcomes of Asbestos Exposure – A Pathology and Diagnostic Perspective;Health Risk Assessment for Asbestos and Other Fibrous Minerals;2024-07-12

3. Loss of MTAP Expression by Immunohistochemistry Is a Surrogate Marker for Homozygous 9p21.3 Deletion in Urothelial Carcinoma;Modern Pathology;2024-06

4. Recent Advances in Mesothelioma;Current Pulmonology Reports;2024-05-23

5. Sarcomas and sarcomatoid neoplasms of the lungs and pleural surfaces;Practical Pulmonary Pathology;2024